This acquisition presents an opportunity for us to help Cianflone further capitalize on existing business today, while also serving as a springboard to achieve significant growth tomorrow...
Pittsburgh, PA (PRWEB) April 15, 2015
Main Line Equity Partners today announced the acquisition of Cianflone Scientific Instruments Corp., a global manufacturer of laboratory and portable x-ray spectrographic instrumentation. The acquisition, which includes all business assets and real estate property, serves as the first initiative in Main Line Equity Partners’ plans to invest in and significantly grow Cianflone.
Doug Hart, Main Line Equity Partners’ newest Operating Partner, will become Cianflone’s General Manager and oversee all strategic and operational efforts moving forward. Leveraging his 25 years of proven leadership as Owner, Operator, and Advisor of businesses across a wide variety of manufacturing and consumer products industries. Hart will play a key role in enhancing Cianflone’s product and service portfolio for future customers, as well as new business opportunities with over 500 current customers.
“For over three decades, Cianflone has built a solid, credible reputation for the niche products they provide in the industries they serve,” said Doug Hart, Operating Partner at Main Line Equity Partners. “This acquisition presents an opportunity for us to help Cianflone further capitalize on existing business today, while also serving as a springboard to achieve significant growth tomorrow.”
About Cianflone Scientific Instruments
Cianflone Scientific Instruments Corp. manufactures portable x-ray spectrographic instrumentation for on-site chemical analysis and coating thickness measurements, and related laboratory sample preparation equipment. Since 1984, we have served industries such as automotive, mining, and petroleum. Product demonstrations and user/operator training are available. Cianflone is headquartered in Pittsburgh, PA, serving customers worldwide.
About Main Line Equity Partners
Main Line Equity Partners is focused on investing in profitable, next stage growth companies, with under $10 million in revenue, looking to engage strategic break-through capital and operational support to increase market share and accelerate earnings growth. Our participation goes beyond the capital and quarterly board meetings. We are actively engaged with our portfolio companies throughout the investment lifecycle as a trusted strategic and operational partner to provide a stable platform to manage growth alongside strong, forward-thinking management teams.